Valeant Enters Super Bowl Frenzy With 30 Second $4.5 Million Toe Fungus Ad
Interesting Super Bowl advertising news is afoot.
Valeant Pharmaceuticals International is running a 30-second spot during the big game's third quarter, Adweek has learned. The ad will push Jublia, a topical solution approved last June by the Food and Drug Administration that's designed to treat onychomycosis, a fungal infection of toe nails.
Hey, check out all the research scientist jobs. Post your resume today!
Valeant Pharmaceuticals International is running a 30-second spot during the big game's third quarter, Adweek has learned. The ad will push Jublia, a topical solution approved last June by the Food and Drug Administration that's designed to treat onychomycosis, a fungal infection of toe nails.
Hey, check out all the research scientist jobs. Post your resume today!